Lettmann Jason (CIK 0001688269)

Latest company ownership

Shares held
597,500
Last filed at
Oct 16, 2025
Confidence Score
53.9
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 16, 2025 Sep 18, 2025 ALX ONCOLOGY HOLDINGS INC CEO Buy 95.0 +92,233 43.32% ✗ $99.4K
Aug 15, 2025 Aug 19, 2025 ALX ONCOLOGY HOLDINGS INC CEO Sell 27.5 -2,382 -1.11% ✗ $1.5K
Feb 19, 2025 Feb 21, 2025 ALX ONCOLOGY HOLDINGS INC CEO Sell 27.5 -2,159 -1.25% ✗ $2.5K
Aug 14, 2024 Aug 16, 2024 ALX ONCOLOGY HOLDINGS INC CEO Sell 27.5 -2,191 -1.28% ✗ $5.7K
Mar 14, 2024 Mar 18, 2024 ALX ONCOLOGY HOLDINGS INC CEO Buy 83.8 +4,400 2.63% ✗ $49.8K
Dec 13, 2021 Dec 15, 2021 ALX ONCOLOGY HOLDINGS INC Director Sell 16.3 -325,377 -2.20% ✗ $8.9M
Dec 8, 2021 Dec 10, 2021 ALX ONCOLOGY HOLDINGS INC Director Sell 27.5 -145,637 -0.72% ✗ $4.7M
Jul 21, 2020 Jul 21, 2020 ALX ONCOLOGY HOLDINGS INC Director Buy 100.0 +400,000 100.00% ✗ $7.6M